Monoclonal gammopathies of undetermined significance

被引:73
作者
Kyle, RA [1 ]
Rajkumar, SV
机构
[1] Mayo Clin & Mayo Fdn, Div Hematol & Internal Med, Rochester, MN 55905 USA
[2] Mayo Clin & Mayo Grad Sch Med, Rochester, MN 55901 USA
关键词
D O I
10.1016/S0889-8588(05)70120-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Monoclonal gammopathy of undetermined significance (MGUS) occurs in approximately 3% of persons older than 70 years. One fourth will develop multiple myeloma, primary amyloidosis, macroglobulinemia, or other lymphoproliferative disorders during long-term follow-up. The plasma cell labeling index and the presence of circulating plasma cells in the peripheral blood are indicators of active disease.
引用
收藏
页码:1181 / +
页数:23
相关论文
共 115 条
[1]  
ALEXANIAN R, 1975, ARCH INTERN MED, V135, P62, DOI 10.1001/archinte.135.1.62
[2]   Prevalence of monoclonal gammopathies in patients with hepatitis C virus infection [J].
Andreone, P ;
Zignego, AL ;
Cursaro, C ;
Gramenzi, A ;
Gherlinzoni, F ;
Fiorino, S ;
Giannini, C ;
Boni, P ;
Sabattini, E ;
Pileri, S ;
Tura, S ;
Bernardi, M .
ANNALS OF INTERNAL MEDICINE, 1998, 129 (04) :294-298
[3]  
ANNESLEY TM, 1982, MAYO CLIN PROC, V57, P572
[4]  
AXELSSON U, 1986, ACTA MED SCAND, V219, P519
[5]  
AXELSSON U, 1966, ACTA MED SCAND, V179, P235
[6]   MALIGNANT LYMPHOMA AND LYMPHATIC LEUKEMIA ASSOCIATED WITH MYELOMA-TYPE SERUM PROTEINS [J].
AZAR, HA ;
HILL, WT ;
OSSERMAN, EF .
AMERICAN JOURNAL OF MEDICINE, 1957, 23 (02) :239-249
[7]  
Badley A D, 1996, Liver Transpl Surg, V2, P375, DOI 10.1002/lt.500020508
[8]   Role of different hematologic variables in defining the risk of malignant transformation in monoclonal gammopathy [J].
Baldini, L ;
Guffanti, A ;
Cesana, BM ;
Colombi, M ;
Chiorboli, O ;
Damilano, I ;
Maiolo, AT .
BLOOD, 1996, 87 (03) :912-918
[9]   PLASMA-CELL DYSCRASIA WITH POLYNEUROPATHY, ORGANOMEGALY, ENDOCRINOPATHY, M PROTEIN, AND SKIN CHANGES - THE POEMS SYNDROME - REPORT ON 2 CASES AND A REVIEW OF THE LITERATURE [J].
BARDWICK, PA ;
ZVAIFLER, NJ ;
GILL, GN ;
NEWMAN, D ;
GREENWAY, GD ;
RESNICK, DL .
MEDICINE, 1980, 59 (04) :311-322
[10]   SERUM LEVELS OF INTERLEUKIN-6, A POTENT MYELOMA CELL-GROWTH FACTOR, AS A REFLECT OF DISEASE SEVERITY IN PLASMA-CELL DYSCRASIAS [J].
BATAILLE, R ;
JOURDAN, M ;
ZHANG, XG ;
KLEIN, B .
JOURNAL OF CLINICAL INVESTIGATION, 1989, 84 (06) :2008-2011